Last reviewed · How we verify
NCT04180553: AORTUS
Ultrasound-Guided Resuscitation in Open Aortic Surgery
NA trial testing Point of Care Ultrasound (POCUS) in Aortic Diseases in 40 participants. Status unknown.
30 October 2021
Quick facts
| Lead sponsor | London Health Sciences Centre |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 15 January 2020 |
| Primary completion | 30 October 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Point of Care Ultrasound (POCUS)
- Usual Care
Conditions studied
- Aortic Diseases — all drugs for Aortic Diseases →
Sponsor
London Health Sciences Centre — full company profile →
Who can join
18 and older, any sex, with Aortic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will aim to determine whether routine Point of Care Ultrasound (POCUS) assessment of volume status, cardiac function, and pulmonary function after major abdominal aortic surgery is an accurate and feasible form of monitoring for individualized, goal-directed resuscitation. Half of the patients will receive POCUS-guided fluid resuscitation, and the other half will be resuscitated using usual post-operative care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04180553
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Diseases
Currently open trials in the same condition.
- NCT07117825 — Aortic Dissection fAlse enlarGement radIomics predictiOn · active not recruiting
- NCT06199401 — Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery · NA · recruiting
- NCT07034430 — Aortic Dilatation Under 5 cm: Genetic Risk Mapping · active not recruiting
- NCT05972018 — Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters · Phase 4 · recruiting
- NCT06358248 — Standardized Physician-modified Fenestrated Endograft Registry · recruiting
Other London Health Sciences Centre trials
Trials by the same sponsor.
- NCT04907071 — Intravascular Ultrasound for the Evaluation of Malperfusion Syndrome in the Setting of Acute Aortic Dissection · NA · completed
- NCT03747536 — Ipratropium Bromide Spray as Treatment for Sialorrhea in Children · Phase 2 · unknown
- NCT03216629 — Sorry Not Sorry: Apologizing and Its Effect on Discomfort During Dressing Removal · NA · completed
- NCT03605030 — Reducing Radiation Exposure to Operators During Invasive Cardiac Procedures · NA · completed
- NCT01087450 — The Effect of Erythropietin on Microcircualtory Alteration in Intensive Care Unit Patients With Severe Sepsis · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04180553 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by London Health Sciences Centre
- Last refreshed: 24 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04180553.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing